| 7.09 0.14 (2.01%) | 04-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.65 | 1-year : | 9.56 |
| Resists | First : | 7.4 | Second : | 8.18 |
| Pivot price | 7.12  |
|||
| Supports | First : | 6.13 | Second : | 5.1 |
| MAs | MA(5) : | 7.09 |
MA(20) : | 7.21 |
| MA(100) : | 6.74 |
MA(250) : | 7.5 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 41.4 |
D(3) : | 44.4 |
| RSI | RSI(14): 48.5 |
|||
| 52-week | High : | 14.1 | Low : | 4.13 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ INGN ] has closed above bottom band by 47.9%. Bollinger Bands are 21% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.2 - 7.22 | 7.22 - 7.26 |
| Low: | 6.7 - 6.73 | 6.73 - 6.76 |
| Close: | 7.03 - 7.08 | 7.08 - 7.14 |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Thu, 18 Apr 2024
Here's Why You Should Retain Inogen in Your Portfolio Now - Yahoo Movies UK
Mon, 15 Apr 2024
Inogen, Inc. (NASDAQ:INGN) Sees Significant Decrease in Short Interest - MarketBeat
Sat, 13 Apr 2024
Inogen Stock: New Management And A Major Competitor Exit Offer Opportunities (NASDAQ:INGN) - Seeking Alpha
Wed, 10 Apr 2024
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024 - Business Wire
Thu, 28 Mar 2024
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio - Zacks Investment Research
Mon, 25 Mar 2024
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 23 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 93.7 (%) |
| Shares Short | 1,690 (K) |
| Shares Short P.Month | 1,890 (K) |
| EPS | -4.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.77 |
| Profit Margin | -32.5 % |
| Operating Margin | -28.7 % |
| Return on Assets (ttm) | -11 % |
| Return on Equity (ttm) | -40.8 % |
| Qtrly Rev. Growth | -13.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 13.53 |
| EBITDA (p.s.) | -1.96 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | -1.61 |
| PEG Ratio | 0 |
| Price to Book value | 0.8 |
| Price to Sales | 0.52 |
| Price to Cash Flow | -51.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|